June 27, 2019
“Restrictive insurance policies keep patients from the very medications that can prevent and treat [headache and migraine disease],” asserts the…
June 20, 2019
“It was so bad. It just wouldn’t quit.” Sara, a new patient, was sitting in my office describing a migraine attack that had led to a recent hospitalization.
May 31, 2019
Migraine disease exists on a spectrum, presenting patients with different frequencies of attacks, whose duration and effect vary from person to person.
February 14, 2019
It might mean swapping out fluorescent light bulbs, implementing a flexible work schedule, or providing a dark room where staff can recover from migraine attacks.
January 10, 2019
On top of debilitating pain and widespread stigma, patients with migraine now face another challenge. If they want preventive treatment, they must first find a physician that their health plan will allow to prescribe it.
September 10, 2018
When it comes to migraine and headache disorders, women have clear-cut opinions – and distinctly female experiences.
May 2, 2018
It’s a new drug, but the same old story. The Institute for Clinical and Economic Review recently reported that preventive treatments for migraine may not, in their interpretation, be cost effective. Known as CGGRP inhibitors, the drugs offer patients and health care providers the chance to not just treat but prevent debilitating migraine headaches.
April 25, 2018
Migraine is one of the most prevalent neurological disorders worldwide, associated with substantial health, sociological, and economic consequences. The current…
February 16, 2018
In a Tuesday policy panel sponsored by The Headache and Migraine Policy Forum, experts from across the health care and veterans support spectrum weighed in on how migraine and headache disorders impact veterans – and whether these women and men can access the treatment they need.
December 12, 2017
What are new drugs to prevent migraine worth? The question is driving a forthcoming report from cost-effectiveness giant the Institute for Clinical and Economic Review (ICER) – and already eliciting an outpouring of feedback from the migraine patient community.
